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Objective: There is continuing controversy as to whether surgical bypass or angioplasty should be first-line treatment of
severe limb ischemia. We undertook this study to examine angiographic and clinical factors that influence the treatment
of severe limb ischemia by vascular surgeons and interventional radiologists.
Methods: Twenty consultant vascular surgeons and 17 consultant vascular interventional radiologists evaluated 596
hypothetical clinical or angiographic scenarios, and recorded whether, in their opinion, the most appropriate first-line
treatment was surgical bypass, angioplasty, or primary amputation. Stepwise multiple linear regression was used to
identify the factors that significantly affected responses from the entire group and from surgeons and radiologists
separately.
Results: There were significant differences between surgeons and radiologists with regard to how clinical and angiographic
variables determined treatment preferences. Increasing disease severity, absence of runoff into the foot, presence of a
suitable vein, and tissue loss as opposed to rest pain only (the latter only significant to surgeons) all increased the response
score toward surgery. However, surgeons and radiologists weighted each of these factors quite differently. Even in the
most complex statistical model, 19% of surgical and 13% of radiologic response variations remained unexplained.
Conclusions: Individual surgeons and radiologists vary considerably in their views of the relative merits of surgery and
angioplasty in patients with severe limb ischemia. This broad gray area mandates the need for randomized controlled trial
data to inform joint decision-making and to optimize patient outcome. (J Vasc Surg 2004;39:1026-32.)In the United Kingdom (population about 56 million
persons), at least 20,000 patients with severe limb ischemia
are seen each year.1 Percutaneous angioplasty, either trans-
luminal or subintimal,2,3 is frequently used as first-line
treatment, but, despite several theoretical advantages over
bypass surgery, this practice is not evidence-based. The
relative indications for bypass surgery and percutaneous
transluminal angioplasty in severe limb ischemia remain
controversial, with strongly held and opposing views ex-
pressed.4-8 The UK Bypass versus Angioplasty for Severe
Ischaemia of the Leg (BASIL) trial is an ongoing, multi-
center, randomized, controlled trial that aims to compare
the clinical and cost-effectiveness of “surgery first” with
“angioplasty first” in patients with severe limb ischemia
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doi:10.1016/j.jvs.2004.01.0311026caused by infrainguinal disease.9 To define the level of
agreement and disagreement among individual vascular
surgeons and interventional radiologists with regard to the
relative merits of surgery versus angioplasty in patients with
severe limb ischemia, and to establish the breadth of the
“gray area of clinical equipoise” for the trial, we conducted
a Delphi consensus study. The main findings have been
published, and indicate substantial levels of disagreement
between and among surgeons and radiologists with regard
to the appropriateness of surgery or angioplasty to treat
severe limb ischemia over a wide range of clinical and
angiographic severity of disease.10,11 The panellists dis-
agreed about the appropriateness of treatment with angio-
plasty, bypass surgery, or primary amputation in 81% of the
scenarios in round 1 and 67% in round 2. Disagreement was
greater among surgeons compared with radiologists in
both round 1 (83% vs 65%) and round 2 (69% vs 42%).8
Surgeons also demonstrated less convergence between
rounds.8
We present a further, novel, and more detailed statisti-
cal analysis of the data, which seeks to determine the
reasons for preferences toward surgery or angioplasty in
terms of the patients’ clinical presentation and their angio-
graphic pattern of disease.
METHODS
Overview. Although the methods involved in the Del-
phi process are published elsewhere,8 we will outline the
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model presented below. The Delphi method is a well-
respected technique for establishing the level of agreement
and disagreement among “experts,” and has been widely
used in the field of medicine. Where substantial disagree-
ment is revealed, the technique can also be used as a vehicle
to build consensus. In brief, a panel of experts is presented
with a range of hypothetical patient scenarios and asked,
without conferring, to indicate which of a range of treat-
ment options offered they would most strongly support.
Individual experts are then fed back their responses to each
of the scenarios and the anonymous responses of the other
panel members. In this way each expert can visualize where
their views and practice lie in relation to those of their peers.
Armed with these insights, the experts are asked to repeat
the exercise, again without conferring, and are permitted to
change their responses to each scenario if they so wish. By
analyzing first-round and second-round responses, one can
establish the level of agreement and disagreement, and the
presence and size of any convergence or divergence be-
tween rounds.
In the context of BASIL, it became apparent that many
of the vascular surgeons and radiologists who had indicated
a willingness to participate had strong and fixed views as to
the relative merits of surgery and angioplasty when it came
to treatment in individual patients. It was apparent, and
often freely admitted by the physicians concerned, that
these fixed ideas were largely a product of the particular
institution in which they had trained, intuition, and the
relative availability of surgical and radiologic resources, rather
than a critical appraisal of a sound evidence base, which does
not exist. Nevertheless, we believed that these fixed ideas were
likely to hamper recruitment into the BASIL trial and that a
Delphi consensus study was probably the best way of demon-
strating to potential participants that, as there was substantial
disagreement between individual physicians and a broad gray
area of clinical equipoise, it was scientifically and ethically
appropriate to randomize their patients.
We therefore conducted a two-round Delphi consensus
study with the help of a panel of 20 consultant surgeons and
17 consultant interventional radiologists who had initially
expressed willingness to participate in the BASIL trial (see
Appendix). Each panellist was presented with 149 angio-
graphic representations of the lower limb ranging from
minimal to severe disease. For each scenario we asked
panellists to score their preferences for bypass surgery,
angioplasty, or primary amputation on an 8-point scale.
Further, they were asked to score each angiographic repre-
sentation four separate times, on the basis of whether the
patients had rest pain only or tissue loss, and whether a
suitable vein was available for bypass. This meant that each
panellist scored 596 scenarios. The median and range of
these first-round responses for each scenario were then fed
back to panellists so that each could see where their re-
sponses lay in relation to those of their peers. Panellists were
given the opportunity to amend their responses in a second
round by completing the questionnaire again. These meth-
ods are described in more detail below.Angiographic representations. The initial intention
was to distribute angiograms to participants; however, it
soon became apparent that this was going to be logistically
impossible. It was therefore decided to provide participants
with angiographic diagrams (Fig). This involved balancing
the requirement to include enough detail to enable in-
formed decision- making, while being aware that diagrams
would have to simplify the hundreds of possible disease
combinations that might be seen at angiography.
As the BASIL trial considers only patients with infrain-
guinal disease, we decided to depict the three main infrain-
guinal segments (superficial femoral artery [SFA], popliteal
artery, and crural arteries) with either no disease, focal
(10 cm) nonocclusive disease, diffuse (10 cm) nonoc-
clusive disease, short (10 cm) occlusion, or long (10
cm) occlusion. In disease scenarios that included a long
occlusion of the crural arteries, participants were also asked
to consider their response in the presence of a patent (with
runoff) and occluded (without runoff) pedal arch. It was
not possible to depict the three crural arteries separately,
because that would have created too many scenarios. We
decided therefore to depict the “best” crural artery and ask
Angiographic representation used in questionnaire.
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three crural vessels and thus the likely target artery for
surgical or endovascular treatment. Allowing for all possi-
ble disease combinations, this resulted in a total of 149
angiographic representations.
Clinical severity of disease and presence of suitable
vein for bypass. Participants were asked to consider each
angiographic representation in the presence of rest pain
only versus tissue loss (ulcer, gangrene), and in addition to
consider each angiographic representation in the presence
of a suitable vein for bypass versus no suitable vein. This led
to a total of 4 times 149, or 596, possible scenarios.
Scoring. For each of the 596 angiographic or clinical
scenarios, respondents were asked to score their preferred
treatment option as follows:
1. Could be treated only with angioplasty.
2. Could be treated with angioplasty or surgery, but I
strongly prefer angioplasty.
3. Could be treated with angioplasty or surgery, but I
prefer angioplasty.
4. Could be treated with angioplasty or surgery, and I have
no preference.
5. Could be treated with angioplasty or surgery, but I
prefer surgery.
6. Could be treated with angioplasty or surgery, but I
strongly prefer surgery.
7. Could be treated only with surgery
8. Not amenable to revascularization; I would advise pri-
mary amputation.
We decided to include a primary amputation category
because in real life that would be a reasonable and appro-
priate treatment choice in certain patients. The primary
amputation category was placed at the surgical end of the
response spectrum because it was thought that primary
amputation would normally be considered only when the
extent and severity of disease was greatest, which was also
thought likely to be the case for surgical bypass.
Assumptions. In reaching their decision, participants
were asked to make four assumptions:
1. There was no significant suprainguinal or profunda fem-
oris artery disease.
2. Medical therapy had failed, and revascularization, either
by surgery, angioplasty, or primary amputation was the
only option.
3. Apart from the information provided, there were no
other contraindications to either surgery or angioplasty.
4. The crural artery depicted was the least diseased of the
three, and thus likely to be the target artery for surgical
or endovascular treatment.
Statistical analysis. Multiple linear regression was
used to determine which factors influenced treatment pref-
erence in round 1. A data point was generated for each of
the 596 scenarios. The mean response over all observerswas used as the dependent variable. Six predictive factors
were considered. The four angiographic factors were the
extent of disease in the superficial femoral, popliteal, and
crural arteries, and whether there was runoff into the foot
(in scenarios that included a long occlusion of the crural
vessels). The two clinical factors were the presence of rest
pain or tissue loss and the presence or absence of a suitable
vein.
In the first statistical model, variables with more than
two response categories (superficial femoral, popliteal, and
crural artery disease status) were entered into the model as
ordinal variables. This model assumed that any difference in
observed response from one category to the next most
severe was the same for all categories. For example, any
difference in response or score from focal nonocclusive
disease (score 2) to diffuse nonocclusive disease (score 3)
was equal to that from short occlusion (score 4) to long
occlusion (score 5). Stepwise regression was used for this
analysis; main effects and interactions entered and left the
model at the 5% and 1% significance levels, respectively.
The stepwise procedure started with no variables in the
model. Step 1 examined all one-variable models, and the
variable that was most predictive of the dependent variable,
and was statistically significant at the 5% level, entered the
model. Step 2 examined all two-variable models, with one
of the variables being the variable selected in step 1. At each
step existing variables were examined, and if any main
effects (if no interactions containing that main effect were
in the model) or any interactions became nonsignificant at
the 5% and 1% levels, respectively, they were removed from
the model. This process was continued until all variables
not already in the model were nonsignificant at the 5% level.
The higher the predicted mean score, the more respon-
dents favored surgery. The standard error, a measure of
variability of the parameter estimate, was also calculated.
When using ordinal variables, the importance of the various
factors was examined with the t statistic, which is the
parameter estimate divided by its standard error. The
higher the t statistic, and the smaller the P value, the more
predictive the factor was of the response.
A further statistical model was used to investigate the
assumption made in the first model that observed response
from one category to the next most severe was the same for
all categories. In the second statistical model the disease
state of the arteries was treated as a categorical variable; that
is, this model did not assume that the observed change in
response would be equal between successive states of dis-
ease in the arteries (ie, not necessarily a linear relationship
between successive states). To simplify the process, interac-
tion terms were not used in this model. For this model,
analysis of variance was used to determine which factors
predicted mean score. Least square means were calculated
for each severity category for each factor. These give the
mean response for a particular severity category for one
factor, assuming an average disease severity level for all the
other factors in the model.
JOURNAL OF VASCULAR SURGERY
Volume 39, Number 5 Bradbury et al 1029RESULTS
Analysis with ordinal variables and interactions
All respondents. All single clinical and angiographic
variables, except rest pain versus tissue loss, entered the final
model, which explains 70% of the total variability in mean
response scores. Of the single factors that are statistically
significant, the presence or absence of a suitable vein is the
least important (lowest t statistic; Table I). With most of the
interaction terms, because their parameter estimates are
negative, an increase in the severity of (in particular, SFA)
disease does not lead to as great an increase in mean
response score as might be expected from the previous
single variables. That is, increasing severity of crural disease,
presence of suitable vein, and lack of runoff into the foot
increases the mean toward surgery, but the respondents’
enthusiasm for surgery is dampened in comparison to that
anticipated if the effects of interaction terms had not been
Table I. Stepwise linear regression comparing factors that
influenced surgeon and radiologist treatment preferences





Superficial femoral artery 0.70 0.06 12.8 .001
Popliteal artery 0.45 0.05 9.3 .001
Runoff into foot 1.83 0.22 8.4 .001
Crural arteries 0.47 0.07 6.8 .001
Suitable vein or not 0.56 0.19 3.0 .0027
Runoff-vein 0.76 0.17 4.5 .001
SFA crural 0.05 0.02 3.5 .0005
Popliteal crural 0.04 0.01 3.3 .0011
Crural-vein 0.12 0.04 2.8 .0058
SFA-vein 0.10 0.04 2.7 .0078
SFA-runoff 0.16 0.06 2.6 .0097
Intercept 0.21 0.25 0.9 .3917
Surgeons only
Superficial femoral artery 0.72 0.06 12.8 .001
Popliteal artery 0.54 0.05 10.8 .001
Runoff into foot 2.11 0.23 9.1 .001
Crural arteries 0.61 0.07 8.9 .001
Suitable vein or not 0.90 0.14 6.6 .001
Rest pain versus tissue loss 0.01 0.06 0.2 .8429
Runoff-pain or tissue loss 0.77 0.15 5.1 .001
Popliteal-crural 0.07 0.01 4.8 .001
SFA-crural 0.06 0.02 3.9 .001
SFA-runoff 0.23 0.06 3.7 .0002
Run-off-vein 0.40 0.15 2.7 .0083
SFA-vein 0.10 0.04 2.6 .0094
Intercept 0.17 0.25 0.7 .4924
Radiologists only
Popliteal artery 0.29 0.02 14.1 .001
Runoff into foot 1.62 0.13 12.9 .001
Superficial femoral artery 0.65 0.05 12.8 .001
Crural arteries 0.34 0.05 6.5 .001
Suitable vein or not 0.20 0.15 1.3 .1826
Runoff-vein 0.96 0.18 5.4 .001
SFA-crural 0.05 0.01 3.8 .001
Crural-vein 0.14 0.05 3.2 .0015
Intercept 0.79 0.20 4.0 .001
PE, Parameter estimate; SFA, superficial femoral vein.considered. This may be largely due to the surgical, as
opposed to the radiologic, response (see below). By con-
trast, the parameter estimate for the interaction term crural
vein is positive; that is, the presence of suitable vein in-
creases the enthusiasm for surgical bypass as the severity of
crural disease increases. Specifically, in the absence of a
suitable vein the increase in mean score (toward surgical
preference) for a 2-point increase in severity of disease in
the crural arteries would be 0.94 (0.47  2); however, in
the presence of suitable vein it would be 1.74 ([0.47  2]
 0.56  [0.12  2]).
Comparison of surgeons and radiologists. The first
statistical model explains 68% and 71% of the total variation
in the mean scores for surgeons and radiologists, respec-
tively. For the surgeons’ model, rest pain versus tissue loss
is in the model, although it is not significant itself (P .84),
because an interaction containing this main effect (runoff
pain, tissue loss) is statistically significant. This also applies
to the radiologists’ model for vein. In general, the radiol-
ogy model is less complex than the surgical model, with
fewer statistically significant interactions. As before, rest
pain versus tissue loss does not affect treatment preference
for the radiologists. Whereas surgical treatment preference
is strongly influenced by the presence of vein (t 6.6; P
.001), this is not the case with the radiologists (t 1.3; P
.18). Of interest, significant interactions differed between
surgeons and radiologists, with the two groups sharing only
two statistically significant interaction terms, namely, SFA,
crural, and runoff vein. As noted, in the group as a whole,
the presence of crural disease, presence of suitable vein, and
lack of runoff into the foot all reduce the mean scores
(indicating a lower preference toward surgery) as SFA
disease severity increased when compared with the single
variables. These three interaction terms (SFA-crural, SFA-
vein, SFA-runoff) are also present in the surgical group but,
with the exception of SFA-crural, not in the radiology
group. It would appear that the combination of these
adverse factors makes surgeons favor surgery, but not so
much as anticipated if the factors were considered sepa-
rately. In contrast, radiologists do not appear to view the
likely failure of surgical bypass an indication for angioplasty.
Analysis with categorical variables and without
interactions
All respondents. When arterial status is entered as a
categorical variable, so that a linear relationship between
response and level of disease is no longer assumed, the final
model is able to explain 86% of response variability. All
variables are statistically significant (P  .0001), including
rest pain versus tissue loss (P  .005). This shows that all
variables had a significant influence on treatment prefer-
ence (Table II).
Assuming an average value for all other factors in the
model, the difference in mean scores between a patient with
a normal SFA (least squares mean, 4.30) and one with a
long occlusion of the SFA (least squares mean, 6.29) is 1.99
(Table III). In other words, a long SFA occlusion results in
a stronger preference for surgical bypass, regardless of other
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with diffuse nonocclusive disease (least squares mean, 5.34)
is thought to be less amenable to angioplasty than an SFA
with a short occlusion (least squares mean, 4.60). The
presence of suitable vein, lack of runoff into the foot, and
the presence of tissue loss all significantly increase the
preference for surgery.
Comparison of surgeons and radiologists. The
models explain 81% and 87% of the total variability for
surgeons and radiologists, respectively. Unlike with the
surgeons, rest pain versus tissue loss does not significantly
influence treatment preferences with the radiologists (P 
.06 for radiologists vs P  .002 for surgeons); all other
variables were statistically significant (P .0001). Surgeons
appear more likely than radiologists to recommend angio-
plasty in patients with diffuse nonocclusive disease, whether
in the SFA, popliteal, or crural arteries. Radiologists are
more inclined toward surgery in scenarios with lack of
runoff into the foot than surgeons are.
Table II. Analysis of variance comparing factors that influe
(categorical variables without interactions)
Factor Level of disease















Vein No suitable vein
Suitable vein




Rest pain or tissue loss Tissue loss
Rest pain
Table III. Percentage of total variability in mean
response scores explained by each statistical model for all















Severe limb ischemia is an increasingly prevalent con-
dition, associated with high morbidity and mortality, and
places huge clinical and financial burdens on health care
and social services.12 Many vascular surgeons believe that
the treatment of choice in all patients is femorodistal bypass
with autologous vein. However, in the United Kingdom
angioplasty is increasingly used as first-line treatment, be-
cause surgery is associated with significant morbidity and
mortality, not all patients have a suitable vein for use as a
conduit, graft patency rates may be disappointing, and
there is lack of health care resources and personnel to
perform the necessary operations. There are also a number
of theoretical advantages to angioplasty; it may be safer, is
quicker, can be repeated, is possibly less expensive, and may
not prejudice surgical bypass if it is unsuccessful. Two small
and imperfect randomized controlled trials have suggested
that in a proportion of patients angioplasty can lead to limb
salvage rates equivalent to surgical bypass.13,14 These data
and the increasing experience with angioplasty to treat
severe limb ischemia in the United Kingdom provide the
scientific rationale and ethical basis on which the BASIL
trial rests. Furthermore, the first Delphi consensus paper
has reported on the substantial levels of disagreement be-
tween and among surgeons and radiologists as to what
constitutes the optimal treatment of severe limb ischemia.
These data also demonstrate a broad gray area of clinical
equipoise for the trial, and reflect the controversy found in
the literature.8
surgeon and radiologist treatment preferences
Least squares mean (standard error)
All Surgeons Radiologists
4.30 (0.05) 4.39 (0.06) 4.19 (0.05)
4.18 (0.05) 4.15 (0.06) 4.21 (0.05)
5.34 (0.05) 5.21 (0.06) 5.50 (0.05)
4.60 (0.05) 4.57 (0.06) 4.62 (0.05)
6.29 (0.05) 6.25 (0.06) 6.32 (0.05)
4.41 (0.05) 4.40 (0.06) 4.43 (0.05)
4.59 (0.05) 4.54 (0.06) 4.65 (0.05)
5.05 (0.05) 4.96 (0.06) 5.15 (0.05)
4.90 (0.05) 4.89 (0.06) 4.91 (0.05)
5.75 (0.05) 5.78 (0.06) 5.71 (0.05)
4.55 (0.06) 4.58 (0.07) 4.51 (0.06)
4.61 (0.06) 4.62 (0.07) 4.60 (0.06)
5.06 (0.06) 4.92 (0.07) 5.21 (0.06)
4.96 (0.06) 4.94 (0.07) 4.99 (0.06)
5.52 (0.03) 5.51 (0.04) 5.54 (0.03)
4.68 (0.04) 4.66 (0.04) 4.71 (0.04)
5.20 (0.04) 5.17 (0.04) 5.23 (0.04)
4.51 (0.02) 4.57 (0.02) 4.44 (0.02)
5.37 (0.06) 5.26 (0.07) 5.50 (0.06)
4.99 (0.04) 4.98 (0.04) 5.00 (0.04)
4.89 (0.04) 4.84 (0.04) 4.93 (0.04)nce
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of the Delphi study by examining in detail the factors that
influence the treatment of severe limb ischemia by vascular
surgeons and interventional radiologists, as reflected in
their responses to the first round of the Delphi process. In
particular, we wished to use statistical modeling to deter-
mine the degree of unexplained response variability and to
examine differences between vascular surgeons and radiol-
ogists.
The complexity of the decision-making process is
readily apparent, despite the fact that respondents were
provided with a much simpler data set than would be the
case in real life. First, the angiographic representations
could not reproduce the many hundreds of different disease
patterns seen at angiography. Second, the clinical informa-
tion was limited to two dichotomous variables, namely, rest
pain versus tissue loss and suitable vein versus no vein. In
reality, vein exhibits a wide spectrum of quality, from
excellent to poor. Third, participants were asked to make a
number of assumptions that should have made decision-
making easier. For example, they could assume that there
was no significant suprainguinal disease, patients were fit
for either treatment, and continued medical treatment was
not an option.
Despite these simplifications, the statistical models still
leave a considerable proportion of the response variability
unexplained (Table III). We attempted to illustrate this by
using two different statistical models, one that incorporated
interactions and one that did not. In this first model the
variables were considered as ordinal data; that is, any differ-
ence in observed response from one category to the next
most severe was the same for all categories. This assumption
is open to debate, although the inclusion of interactions in
an ordinal model does demonstrate the complexity of the
decision-making process. With most of the interaction
terms the respondents’ enthusiasm for surgery is dampened
in comparison with that anticipated if the effects of inter-
action terms had not been considered. This may be largely
due to the surgical, as opposed to the radiologic, response
(see below). Only for the interaction term crural-vein does
the presence of suitable vein increase the enthusiasm for
surgical bypass as the severity of crural disease increases.
When variables were treated as categorical data, the unex-
plained variability decreased, from 30% to 14%. The re-
maining variability to some extent reflects higher order
interactions as well as disagreement among and between
participants.
In both statistical analyses the surgeons’ models are
more complex than those of the radiologists, but explained
less of the response variability. This suggests that surgeons
may take a wider range of variables into consideration when
forming their view. In general, surgeons are more likely to
favor surgical bypass as disease severity, particularly in the
SFA, increases. However, in the first model the inclusion of
interaction terms demonstrated that surgical enthusiasm
for bypass was significantly dampened by the presence of
crural disease, absence of runoff into the foot, and lack of
suitable vein. That is, when the whole picture suggestedthat surgical bypass was likely associated with limited pa-
tency, surgeons still prefer surgery to angioplasty, but to a
lesser extent. Perhaps not surprisingly, radiologists did not
share surgeons’ enthusiasm for angioplasty in these circum-
stances.
The simple categorical model shows that radiologists
are more confident about tackling focal, as opposed to
diffuse, disease. Of some surprise, they appeared to be
almost as confident about treating crural as SFA disease.
Few radiologists appeared enthusiastic to attempt full-
length recanalization of the SFA, possibly because most
radiologists do not practice or have limited experience with
the subintimal technique. In general, for any given severity
and extent of disease, radiologists seemed more enthusias-
tic about surgical bypass than surgeons did, whether or not
there was suitable vein and whether or not the patients had
rest pain only or tissue loss. This is perhaps surprising, given
that all the radiologist respondents were highly experienced
vascular interventionalists. These data may reflect radiolo-
gists’ lack of confidence in angioplasty to treat severe limb
ischemia, because of poor experience with salvage angio-
plasty, lesser appreciation of the advantages of vein, and
possibly an overly optimistic view of the results of pros-
thetic femorocrural bypass.
Taken in conjunction with the results of the Delphi
process,8 these data confirm that there remains consider-
able disagreement among and between surgeons and radi-
ologists with regard to the relative merits of angioplasty and
bypass in the treatment of severe limb ischemia. Present
data indicate that part of this disagreement relates to the
fact that surgeons and radiologists view the risks and ben-
efits of their own and their counterparts’ treatment method
differently in the context of a similar angiographic pattern
of disease and clinical features. This reemphasises the need
for joint surgical and radiologic decision-making and the
need for excellent communication so that colleagues are
not working at cross-purposes or with misconceptions.
Present data suggest that certain surgeons believe that if
surgical bypass is unattractive, then angioplasty should be
attempted, even though it is also likely to be unsuccessful,
because there is nothing to lose by trying. In contrast,
certain radiologists will take on very extensive disease in the
belief that, even if it fails, the procedure can be repeated and
angioplasty does not prejudice the outcome of subsequent
surgical bypass, should it be necessary. It is unlikely that
either of these extreme views represents the most clinically
and cost-effective way of using these two complementary,
not competing, treatment methods. These issues can only
be settled within the confines of a randomized controlled
trial. The BASIL trial is expected to publish its results in
2006.
APPENDIX
The following surgeons and radiologists completed the
Delphi questionnaire:
Mr A. Al-Asadi, Falkirk & District Royal Infirmary
Dr J. Barry, Falkirk & District Royal Infirmary
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May 20041032 Bradbury et alMr J. Beard, Northern General Hospital, Sheffield
Professor T. Buckenham, Edinburgh Royal Infirmary
Mr D. Byrne, Gartnavel General Hospital, Glasgow
Mr R. T. A. Chalmers, Edinburgh Royal Infirmary
Dr T. Clevelands, Northern General Hospital, Shef-
field
Mr S. Cross, Aberdeen Royal Infirmary
Mr J. Duncan, Raigmore Hospital, Inverness
Mr J. Engeset, Aberdeen Royal Infirmary
Dr M. Fleet, Queen Margaret Hospital, Dunfermline
Dr I. N. Gillespie, Edinburgh Royal Infirmary
Mr D. Gilmour, Glasgow Royal Infirmary
Mr G. Griffiths, Ninewells Hospital, Dundee
Dr J. Houston, Ninewells Hospital, Dundee
Ms A. Howd, Queen Margaret Hospital, Dunfermline
Dr S. Ingram, Edinburgh Royal Infirmary
Dr H. Ireland, Queen Margaret Hospital, Dunfermline
Mr A. Jenkins, Edinburgh Royal Infirmary
Mr D. Lambert, Freeman Hospital, Newcastle
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